Jagiellonian University researchers advanced an adipose mesenchymal stem cell-based osteoarthritis therapy, showing promising pain reduction and improved joint function in trials.
BioRestorative's early Phase 2 trial results show notable improvements in function and pain for chronic lumbar disc disease patients, moving one step closer to a BLA.
